Q4 2016 13F Holders as of 31 Dec 2016
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
193,539,047
-
Number of holders
-
404
-
Total 13F shares, excl. options
-
169,392,815
-
Shares change
-
+900,807
-
Total reported value, excl. options
-
$14,033,179,313
-
Value change
-
+$56,824,379
-
Put/Call ratio
-
1.24%
-
Number of buys
-
195
-
Number of sells
-
-203
-
Price
-
$82.84
Significant Holders of BIOMARIN PHARMACEUTICAL INC - Common Stock, par value $0.001 per share (BMRN) as of Q4 2016
503 filings reported holding BMRN - BIOMARIN PHARMACEUTICAL INC - Common Stock, par value $0.001 per share as of Q4 2016.
BIOMARIN PHARMACEUTICAL INC - Common Stock, par value $0.001 per share (BMRN) has 404 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 169,392,815 shares
of 193,539,047 outstanding shares and own 87.52% of the company stock.
Largest 10 shareholders include Capital Research Global Investors (19,643,043 shares), VANGUARD GROUP INC (13,207,286 shares), SANDS CAPITAL MANAGEMENT, LLC (9,380,802 shares), JENNISON ASSOCIATES LLC (9,263,458 shares), FMR LLC (8,890,514 shares), PRIMECAP MANAGEMENT CO/CA/ (7,885,948 shares), BAKER BROS. ADVISORS LP (4,806,483 shares), BlackRock Institutional Trust Company, N.A. (4,373,022 shares), BlackRock Fund Advisors (4,288,652 shares), and STATE STREET CORP (3,743,112 shares).
This table shows the top 404 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.